Reported Jan 21, 2026 · Ongoing

Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah,…

Alvogen, Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Alvogen, Inc · 44 Whippany Rd Ste 300 · Morristown, NJ · 07960-4558

Is this the product you have?

  • Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only
  • Manufactured byLLOYD, Inc., Shenandoah, IA, 51601 USA
  • Distributed byAlvogen, Inc., Pine Brook, NJ 07058 USA
  • NDC47781-662-10
Lot codes and dates
  • Lot # MHA21825
  • Exp Date
    • December 31
    • 2027

Where it was sold

  • Nationwide

Why it was recalled

Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Alvogen, Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 5:54 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.